Activity and safety of pegylated liposomal doxorubicin, 5-fluorouracil and folinic acid in inoperable hepatocellular carcinoma: A phase II study

AIM: To improve the results of New therapeutic strategies in hepatocellular carcinoma (HCC). We have conducted a phase II study with pegylated liposomal doxorubicin (PLD), 5-fluorouracil (5FU) and folinic acid (FA). METHODS: Thirty-one patients with hystologically-confirmed, inoperable HCC, received...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Gastroenterol
Main Authors: Lorenzo, Giuseppe Di, Rea, Antonio, Carlomagno, Chiara, Pepe, Stefano, Palmieri, Giovannella, Labianca, Roberto, Chirianni, Antonio, Stefano, Alfonso De, Esposito, Vincenzo, Placido, Sabino De, Montesarchio, Vincenzo
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Co., Limited 2007
Assuntos:
Rapid Communication
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4611295/
https://ncbi.nlm.nih.gov/pubmed/18161926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v13.i48.6553
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados